Pacific Health Care Organization AI Stock Analysis
Want to see PFHO full AI Analyst Report?
Pacific Health Care Organization (PFHO) AI Stock Analysis
Pacific Health Care Organization
(Other OTC:PFHO)
The overall score of 78 is heavily driven by PFHO's pristine financial health, notably its debt-free capital structure and excellent cash flow generation. The stock's highly attractive valuation (11.2 P/E) and positive short-term technical momentum further strengthen the score. Minor risks are present in the form of recent revenue headwinds and a lagging long-term price trend against the 200-day moving average.
Pacific Health Care Organization (PFHO) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $14.08M
- Dividend Yield
- ―
- Average Volume (3M)
- 7,203
- Price to Earnings (P/E)
- 12.9
- Beta (1Y)
- -0.01
- Revenue Growth
- -4.58%
- EPS Growth
- -24.73%
- Country
- US
- Employees
- 30
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Plans
Pacific Health Care Organization Business Overview & Revenue Model
Company Description
Pacific Health Care Organization, Inc. (PFHO), along with its various subsidiaries, specializes in providing targeted managed care services for workers' compensation throughout the United States. The company serves a wide array of clients, including...
Pacific Health Care Organization Financial Statement Overview
Summary
Anchored by an exceptionally conservative, debt-free balance sheet and strong cash conversion (98.2% free cash flow to net income ratio). While there have been recent top-line and gross margin contractions, the company maintains a robust 17.1% net profit margin.
Income Statement
65PositiveBalance Sheet
88Very PositiveCash Flow
85Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.37M | 6.72M | 6.07M | 5.63M | 5.74M | 5.40M |
| Gross Profit | 2.86M | 3.22M | 2.58M | 2.16M | 2.18M | 2.01M |
| EBITDA | 875.31K | 1.03M | 1.30M | 716.06K | 700.12K | 1.25M |
| Net Income | 1.09M | 1.39M | 883.58K | 767.93K | 492.89K | 995.02K |
Balance Sheet | ||||||
| Total Assets | 14.37M | 13.48M | 12.43M | 11.82M | 12.05M | 11.33M |
| Cash, Cash Equivalents and Short-Term Investments | 12.98M | 12.21M | 11.10M | 10.44M | 10.78M | 10.09M |
| Total Debt | 0 | 0 | 35.30K | 56.49K | 60.65K | 70.37K |
| Total Liabilities | 437.49K | 401.85K | 745.60K | 1.02M | 735.07K | 508.46K |
| Stockholders Equity | 13.93M | 13.07M | 11.69M | 10.80M | 11.32M | 10.82M |
Cash Flow | ||||||
| Free Cash Flow | 1.06M | 1.14M | 665.95K | 914.84K | 672.37K | 368.01K |
| Operating Cash Flow | 1.08M | 1.16M | 675.08K | 932.36K | 711.24K | 386.39K |
| Investing Cash Flow | -570.25K | -990.15K | -1.13M | 806.79K | -8.76M | -18.38K |
| Financing Cash Flow | -36.25K | -72.31K | 35.30K | -1.21M | 0 | 218.90K |
Pacific Health Care Organization Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PFHO, the sentiment is Positive. The current price of 1.10 is above the 20-day moving average (MA) of 1.01, above the 50-day MA of 0.99, and above the 200-day MA of 1.05, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 68.05 is Neutral, neither overbought nor oversold. The STOCH value of 97.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PFHO.
Pacific Health Care Organization Risk Analysis
Pacific Health Care Organization disclosed 27 risk factors in its most recent earnings report. Pacific Health Care Organization reported the most risks in the "Production" category.
Latest Risks Added
2 New RisksPacific Health Care Organization Peers Comparison
Overall Rating
PFHO78Outperform
OSCR77Outperform
CLOV72Outperform
CNC66Neutral
ALHC60Neutral
MOH53Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | $14.08M | 12.91 | 8.10% | ― | -4.58% | -24.73% | |
| 77Outperform | $9.86B | 11.17 | 49.48% | ― | 54.77% | ― | |
| 72Outperform | $2.59B | 291.76 | 3.52% | ― | 54.46% | ― | |
| 66Neutral | $34.79B | 24.08 | 6.78% | ― | 9.71% | ― | |
| 60Neutral | $1.57B | 52.27 | 12.46% | ― | 35.87% | ― | |
| 53Neutral | $10.95B | -343.43 | -1.17% | ― | -0.95% | -105.84% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PFHO | Pacific Health Care Organization, Inc. | 1.10 | -0.20 | -15.38% | |
| CNC | Centene | 71.27 | 34.19 | 92.21% | |
| MOH | Molina Healthcare Inc | 209.49 | 72.70 | 53.15% | |
| CLOV | Clover Health Investments Corp | 4.96 | 2.61 | 111.06% | |
| OSCR | Oscar Health, Inc. | 31.05 | 16.80 | 117.89% | |
| ALHC | Alignment Healthcare, Inc. | 7.36 | -8.68 | -54.11% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026
